Selecta Biosciences Inc. (SELB)
NASDAQ: SELB
· Real-Time Price · USD
0.88
-0.08 (-8.12%)
At close: Nov 13, 2023, 10:00 PM
Selecta Biosciences Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 22.66M | 28.11M | 12.19M | 34.53M | 48.69M | 82.72M | 110.78M | 123.92M | 127.64M | 108.03M | 85.08M | 67.09M | 47.31M | 27.65M |
Cost of Revenue | 2.51M | 2.51M | 17.78M | 55.37M | 71.91M | 54.13M | 35.51M | 16.54M | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 18.67M | 25.22M | -5.98M | -20.84M | -23.22M | 28.59M | 75.27M | 107.38M | 127.64M | 108.03M | 85.08M | 67.09M | 47.31M | 27.65M |
Operating Income | 50.08M | 37.02M | -31.7M | -58.58M | -47.11M | -14.62M | 14.54M | 27.11M | 26.74M | 13.33M | -4.6M | -16.57M | -28.34M | -45.16M |
Interest Income | 8.24M | 6.22M | 642K | 1.5M | 1.59M | 949K | 426K | 92K | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -76.98M | -68.27M | -44.57M | -36.45M | -35.66M | -15.67M | 34.77M | 41.54M | 47.69M | 43.65M | -9.72M | -37.54M | -45.21M | -73.85M |
Net Income | -73.17M | -64.47M | -44.57M | -40.25M | -39.14M | -19.15M | 35.38M | 41.73M | 31.72M | 27.69M | -25.69M | -53.37M | -45.21M | -73.85M |
Selling & General & Admin | 26.59M | 24.89M | 19.28M | 24.74M | 23.89M | 24.02M | 23.86M | 23.08M | 22.75M | 21.27M | 20.94M | 20.16M | 19.13M | 20.02M |
Research & Development | 30.38M | 28.7M | 42.18M | 68.38M | 71.91M | 73.31M | 72.38M | 73.73M | 78.14M | 73.42M | 68.74M | 63.51M | 56.52M | 52.78M |
Other Expenses | n/a | n/a | 245K | 675K | 676K | 431K | 330K | 155K | 163K | 169K | 15K | 41K | 37K | 90K |
Operating Expenses | 56.97M | 53.59M | 61.47M | 93.11M | 95.81M | 97.33M | 96.24M | 96.81M | 100.89M | 94.69M | 89.67M | 83.66M | 75.65M | 72.8M |
Interest Expense | -2.83M | -1.56M | 2.02M | 3.64M | 3.17M | 3.13M | 3.03M | 2.94M | 2.84M | 2.84M | 2.84M | 2.85M | 2.5M | 1.99M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 18.52M | 38.14M | 43.5M | 93.11M | 95.81M | 97.33M | 96.24M | 96.81M | 100.89M | 94.69M | 89.67M | 83.66M | 75.65M | 72.8M |
Income Tax Expense | -5.18M | -5.18M | n/a | 3.8M | 3.48M | 3.48M | -609K | -183K | 15.97M | 15.97M | 15.97M | 15.83M | n/a | n/a |
Shares Outstanding (Basic) | 155.11M | 155.11M | 155.11M | 154.8M | 153.44M | 153.35M | 145.87M | 152.85M | 148.51M | 124.23M | 117.79M | 111.84M | 113.52M | 110.74M |
Shares Outstanding (Diluted) | 155.11M | 155.11M | 155.11M | 154.8M | 153.44M | 153.35M | 145.87M | 152.85M | 148.51M | 127.57M | 124.06M | 115.17M | 121.18M | 110.74M |
EPS (Basic) | -0.47 | -0.42 | -0.29 | -0.27 | -0.26 | -0.13 | 0.27 | 0.34 | 0.23 | 0.21 | -0.24 | -0.48 | -0.41 | -0.7 |
EPS (Diluted) | -0.47 | -0.42 | -0.29 | -0.27 | -0.26 | -0.13 | 0.27 | 0.34 | 0.23 | 0.21 | -0.24 | -0.48 | -0.41 | -0.7 |
EBITDA | -40.13M | -53.19M | -31.28M | -57.28M | -45.47M | -13.39M | 15.81M | 27.97M | 27.59M | 14.5M | -3.73M | -15.68M | -27.66M | -44.6M |
EBIT | 41.77M | 31.49M | -20.91M | -35.35M | -32.49M | -12.54M | 37.8M | 44.48M | 50.53M | 46.49M | -6.88M | -34.7M | -42.71M | -71.86M |
Depreciation & Amortization | -826K | -637K | 365K | 1.24M | 1.4M | 1.57M | 1.62M | 1.6M | 1.59M | 1.55M | 1.25M | 1.09M | 890K | 710K |